Back to results
US 2016/0355786 A1Published application
Induction of Hemogenic Endothelium from Pluripotent Stem Cells
AssigneeWisconsin Alumni Research Foundation
InventorsIgor Slukvin, Irina Elcheva
Life of this patent
Estimating the term…
Abstract
Described herein are methods and related compositions for inducing differentiation of human pluripotent stem cells (hPSCs) into hemogenic endothelium with pan-myeloid potential or restricted potential, by forced expression in the hPSCs of a combination of transcription factors as described herein.
Claims3
1-20. (canceled)
A kit for hemogenic reprogramming, comprising:
- (i) one or more isolated nucleic acids comprising an open reading frame for ETV2 or ERG, and GATA1;
- or
- (ii) one or more recombinant expression viruses suitable for expression, in human pluripotent stem cells, of ETV2 or ERG, and GATA1.
The kit of claim 0, wherein the one or more isolated nucleic acids are modified mRNAs.
Dependencies are inferred from the claim text.